Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

DATOPOTAMAB DERUXTECAN-DLNK

FDA · BLA · 2026-05-22

AgencyFDA
Submission typeBLA
Action date2026-05-22
BrandDATROWAY
SponsorDAIICHI SANKYO INC
RouteIV (INFUSION)

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:35:05.745Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:DATOPOTAMAB DERUXTECAN-DLNK:2026-05-22

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

DATOPOTAMAB DERUXTECAN-DLNK — approval | AEaH